Drug profile · INN
paclitaxel
PACLITAXEL ACCORD
paclitaxel (PACLITAXEL ACCORD) is a tubulin inhibitor. Associated with Accord Healthcare Pty.. Route of administration: injection. Current US regulatory status: approved.
Drug details — paclitaxel
- US status
- approved
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- INJECTION
- Patents
- 12
- Programs
- 230
- Data quality
- 0.89
Quick answer
paclitaxel (PACLITAXEL ACCORD) is a tubulin inhibitor. Associated with Accord Healthcare Pty.. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Tubulin inhibitor
Primary target: Tubulin
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
| TGA | approved | — |
| PMDA | approved | — |
| NMPA | clinical trials | — |
Recent coverage
Pipeline programs
Related & competitor drugs
Related patents
-
US 11944617
Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of CYP2C8 and CYP3A4
granted -
US 11439709
Phospholipid ether analogs as cancer-targeting drug vehicles
granted -
US 11285145
Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of CYP2C8 and CYP3A4
granted -
US 9925269
Phospholipid ether analogs as cancer-targeting drug vehicles
granted -
US 9616140
Fluorescent phospholipid ether compounds, compositions, and methods of use
granted -
US 9579406
Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof
granted -
US 9550002
Phospholipid analogs as diapeutic agents and methods thereof
granted -
US 9480754
Phospholipid ether analogs as cancer-targeting drug vehicles
granted -
US 9345718
Phospholipid ether analogs as cancer-targeting drug vehicles
granted -
US 8426385
Pharmaceutical composition comprising cyclodextrin paclitaxel inclusion and preparation method thereof
granted -
US 7179588
Assay for the detection of paclitaxel resistant cells in human tumors
granted -
US 6569459
Method of administration of paclitaxel-plasma protein formulation
expired
Frequently asked questions
What is paclitaxel?
paclitaxel (PACLITAXEL ACCORD) is a tubulin inhibitor. Associated with Accord Healthcare Pty.. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for paclitaxel?
PACLITAXEL ACCORD is a marketed brand name for paclitaxel. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of paclitaxel?
paclitaxel has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.